Article info

Download PDFPDF
Original research
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer

Authors

  • Elias Orouji Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ayush T Raman Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Broad Institute of MIT and Harvard, Cambridge, Massachussetts, USA Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Anand K Singh Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Alexey Sorokin Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Emre Arslan Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Archit K Ghosh Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jonathan Schulz Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Christopher Terranova Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Shan Jiang Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ming Tang Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Mayinuer Maitituoheti Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Scot C Callahan Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Praveen Barrodia Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Katarzyna Tomczak Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yingda Jiang Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Zhiqin Jiang Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jennifer S Davis Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Sukhen Ghosh Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Hey Min Lee Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Laura Reyes-Uribe Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Kyle Chang Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yusha Liu University of Chicago Medical Center, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Huiqin Chen Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Ali Azhdarinia Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jeffrey Morris University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Eduardo Vilar MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Kendra S Carmon MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Center for Translational Cancer Research, University of Texas Health Science Center at Houston, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Scott E Kopetz Department of GI Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Kunal Rai Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas, USA MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kunal Rai, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; krai{at}mdanderson.org
View Full Text

Citation

Orouji E, Raman AT, Singh AK, et al
Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer

Publication history

  • Received August 17, 2020
  • Accepted May 14, 2021
  • First published May 31, 2021.
Online issue publication 
April 08, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.